PRP Facial Rejuvenation

Overview

Platelet-rich plasma (PRP) facial rejuvenation is an autologous regenerative treatment: it uses the patient's own concentrated growth factors — extracted from their blood — to stimulate the skin's repair and collagen synthesis machinery. Because the material is entirely derived from the patient, the risk of allergic reaction or immunogenic response is essentially absent, making it one of the safest regenerative interventions available.

PRP has a well-established evidence base in orthopaedics, wound healing, and hair restoration. In aesthetic medicine, the published evidence for facial skin quality improvement is substantial, with multiple randomised controlled trials demonstrating statistically significant improvements in skin texture, elasticity, and fine rhytids compared to saline control. The treatment mechanism is well-understood, the safety profile is excellent, and the intervention is relatively accessible compared to other regenerative modalities.

Mechanism of Action

Platelets — the anucleate circulating cells primarily known for their role in haemostasis — contain dense granules (alpha-granules and dense bodies) packed with growth factors and signaling proteins that are released on platelet activation. In a wound, platelet activation triggers the growth factor release that initiates the repair cascade. PRP therapy exploits this mechanism: by concentrating platelets 4–8× above the physiological baseline and delivering this concentrate to target tissue, a supraphysiological growth factor signal is created that drives more robust and rapid tissue repair and regeneration than naturally occurs.

The primary growth factors released from PRP alpha-granules in aesthetic applications:

• PDGF (Platelet-Derived Growth Factor): Stimulates fibroblast and keratinocyte proliferation; chemotactic for fibroblasts (recruits them to the treatment site).
• TGF-β (Transforming Growth Factor-beta): Primary driver of collagen type I and III synthesis; modulates the wound-healing response and reduces scar formation.
• VEGF (Vascular Endothelial Growth Factor): Promotes angiogenesis — new capillary formation — improving the vascular supply to treated tissue.
• EGF (Epidermal Growth Factor): Stimulates keratinocyte proliferation and differentiation, improving the epidermal barrier and surface texture.
• IGF-1 (Insulin-like Growth Factor-1): Promotes cell survival, proliferation, and matrix synthesis in fibroblasts and keratinocytes.

Preparation: What Determines PRP Quality

PRP quality is not standardised across practices. The concentration factor (how much the platelet concentration exceeds whole blood baseline), the presence or absence of leucocytes (white blood cells — which can increase inflammation in some applications), the activation status of the platelets, and the processing system used all affect the growth factor payload. A 4–8× platelet concentration is generally considered the minimum for therapeutic effect; some newer double-spin systems produce 10–15× concentration.

The most significant quality variable is the practitioner's centrifugation protocol and PRP system selection. Not all commercially available PRP kits produce equivalent platelet concentrations. Patients should ask their provider what concentration factor their system produces.

Treatment Protocols

PRP + Microneedling (Most Common)

Microneedling creates thousands of microchannels in the skin, dramatically increasing permeability to the topically applied PRP immediately after. The mechanical injury from microneedling also independently stimulates collagen remodelling; the PRP amplifies this response. Sessions are spaced 4–6 weeks apart for a series of 3 treatments. Downtime is 2–4 days of redness and minor swelling.

Intradermal PRP Injection

PRP is injected into the dermis using a fine-gauge needle or cannula in a serial puncture or linear threading technique across the treatment area. This delivers growth factors directly to the fibroblast layer without the need for concurrent microneedling. Particularly useful in the periorbital region and other delicate anatomical areas where aggressive microneedling is less appropriate. Minor bruising is the primary side effect.

PRP for Hair Restoration

Scalp PRP injection protocols for androgenetic alopecia have a substantial evidence base. PRP promotes hair follicle miniaturisation reversal, extends the anagen (growth) phase, and improves follicular vascularity. Protocols typically involve 3–4 monthly sessions followed by quarterly maintenance.

Cost in the United States

Single PRP + microneedling sessions range from $500–$1,200. A standard initial series of 3 sessions ranges from $1,200–$3,500. Injectable PRP sessions at specialist practices range from $800–$1,500 per session. The cost reflects both the preparation process (centrifuge time, phlebotomy, sterile processing) and the clinical time for treatment delivery.

Risks and Contraindications

• Post-inflammatory hyperpigmentation: In Fitzpatrick skin types IV–VI, aggressive microneedling can trigger PIH — minimised by appropriate needle depth selection and avoiding treatment over inflamed skin.
• Bruising: Expected at injection sites; more pronounced in patients on anticoagulants or with fragile capillaries.
• Infection: Rare with proper sterile technique; absolute contraindication to treat over active infection.

Contraindications: Active blood cancers or platelet disorders, anticoagulation therapy (relative — discuss with prescriber), active acne or skin infection at treatment site, and thrombocytopenia. Pregnancy is a relative contraindication (insufficient safety data).